Sleep Medicine Weekly Insider – October 7, 2023
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. FDA issues new statement on recall On Oct. 5, the FDA posted a new [...]
Talking Sleep | Management of Obesity Hypoventilation Syndrome
Talking Sleep Season 5 | Episode 18 Management of Obesity Hypoventilation Syndrome Dr. Babak Mokhlesi,GUEST Obesity hypoventilation syndrome can be challenging to manage. Obtaining the appropriate device for each patient is often complicated by insurance requirements and endless [...]
AASM responds to CMS 2024 physician fee schedule and Quality Payment Program proposed rule
On Thursday, July 13, the Centers for Medicare & Medicaid Services (CMS) filed the 2024 Medicare physician fee schedule and Quality Payment Program proposed rule, which includes potential revisions to payment policies under the physician fee schedule, Quality Payment [...]
AASM teams up with California Sleep Society for Blue Shield of California payer advocacy initiative
The American Academy of Sleep Medicine is teaming up with the California Sleep Society to continue advocating for a change to Blue Shield of California’s current positive airway pressure (PAP) therapy reimbursement policy. The payer recently updated its Medical [...]
Risk of long COVID in people with pre-existing conditions is higher among short sleepers
DARIEN, IL - While infections and hospitalizations from the COVID-19 virus are expected to rise during the fall and winter respiratory virus season, a new study suggests that sleep duration modulates the relationship between pre-existing medical conditions and long [...]
American Academy of Sleep Medicine launches ‘Act on Actigraphy’ campaign to support patient access to care
DARIEN, IL - The American Academy of Sleep Medicine has launched the “Act on Actigraphy” campaign highlighting the importance of actigraphy testing for sleep disorders and urging payers to reimburse health care professionals for this evidence-based medical service, which [...]
2024 AASM Membership is Now Open
As a member of the AASM, you are part of a global community of diverse professionals – physicians, scientists, advanced practice providers, and allied health care professionals who share your passion for advancing sleep care and enhancing sleep health [...]
State of Sleep Medicine Report | 2023, Q3
The State of Sleep Medicine Report is compiled quarterly by the American Academy of Sleep Medicine as a members only resource. The report contains news highlights and announcements to help members identify current trends and innovations in sleep medicine, [...]
Sleep Medicine Weekly Insider – September 30, 2023
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Sleep clinic owner pleads guilty to fraud A former Fresno, California, sleep clinic owner [...]
AASM seeks nominees for 2024 awards
The AASM Awards Advisory Panel is now accepting nominations for the 2024 AASM awards, which recognize outstanding contributions to the field of sleep medicine. AASM members are invited to submit applications nominating individuals who embody the attributes of [...]
Marijuana use leads to lost sleep for half of Americans
According to a new survey, about half (49%) of Americans have lost sleep due to staying up past their bedtime to use marijuana. This is more common among younger generations, with more than half of millennials (58%) and those [...]
Honeynaps receives FDA approval for AI sleep disorder diagnosis software
Honeynaps announced Sep. 25, 2023, that its SOMNUM artificial intelligence (AI) sleep disease analysis algorithm received FDA approval. The software leverages deep learning-based AI to perform real-time analysis of vast volumes of biosignals. About SOMNUM SOMNUM is software intended [...]
Sleep Medicine Weekly Insider – September 23, 2023
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. First patient dosed in Apnimed trial Apnimed announced the first patient dosed in its [...]
Talking Sleep | Insufficient sleep, circadian disruption and cardiometabolic health
Talking Sleep Season 5 | Episode 17 Insufficient sleep, circadian disruption and cardiometabolic health Dr. Christopher Depner, GUEST We frequently discuss how insufficient sleep may be harmful to cardiometabolic health, but is this the whole story? How does [...]
Read Montage magazine issue two of 2023
Welcome to the latest edition of Montage, the AASM member magazine. In this issue, Dr. James Rowley, AASM president, reflects on changes in his career, the field of sleep medicine and at the AASM. The AASM Emerging Technology [...]
The sleep center that could: A success story of establishing and expanding behavioral sleep medicine in a medical sleep center
Although sleep centers have significantly improved access to sleep medicine, we often lack psychologists with specialty expertise in sleep medicine on our teams. Consequentially, most sleep centers are unable to offer the first-line, recommended behavioral therapies to patients with [...]
Novel devices and applications for diagnosing obstructive sleep apnea
The field of sleep medicine and the technologies that support sleep specialists continue to rapidly evolve. Newer technologies used for prescreening and diagnosing obstructive sleep apnea are not just smaller or more portable. They may use novel sensors, locations, processing, [...]
Author on quest to unlock the secrets of sleep and dreams
Army veteran, retired professor, and author Dr. Francesco Ancona lives a life of exploration and learning. Fascinated by sleep and dream interpretation, Dr. Ancona inspired students’ curiosity for more than 30 years and penned everything from scholarly texts to [...]
Sleep in ancient Greece and Rome
From the beginning of recorded time, sleep has played a central role in human lives, and several theories regarding sleep have been advanced and described throughout the centuries. Sleep was considered both a method of healing and a [...]
Sleep Medicine Weekly Insider – September 16, 2023
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Watch the Disruptors trailer, view agenda Watch the new trailer for Sleep Medicine Disruptors [...]
AASM urges members to complete the AMA Physician Practice Information Survey
The AASM urges physician members to participate in a national study being conducted by the American Medical Association (AMA), and supported by 173 health care organizations including the AASM, to collect representative data on physician practice expenses. The aim [...]
FDA clears AI-assisted sleep monitoring device Dreem 3S
Beacon Biosignals announced in a press release on Sep. 13, 2023 that it received FDA 510(k) clearance for the Dreem 3S, an artificial intelligence (AI)-assisted wearable headband for sleep monitoring. The device allows patients to participate in home-based electroencephalogram [...]
FDA clears circul pro Ring as pulse oximeter
On Sep. 7, 2023, BodiMetrics announced that its circul pro Ring has received FDA 510(k) clearance as a pulse oximeter. According to the company, the device’s form factor and LED technology make it uniquely designed to accurately measure blood oxygen level [...]
Sleep Medicine Weekly Insider – September 9, 2023
The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Philips settles class action lawsuit Philips announced it has reached an agreement to resolve [...]
FDA grants orphan drug status to pitolisant for idiopathic hypersomnia
On Sep. 7, 2023, Harmony Biosciences announced that the FDA granted orphan drug designation to pitolisant for the treatment of idiopathic hypersomnia (IH). The FDA’s orphan drug designation provides incentives for drugs and biologics for the treatment of rare [...]